Screener
CorMedix CRMD Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| COMMITMENTS AND CONTINGENCIES (Note 8) | ||
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock - $0.001 par value: 2,000,000 shares authorized; 91,623 and 91,623 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | - | - |
| Common stock - $0.001 par value: 160,000,000 shares authorized; 78,395,299 and 79,260,667 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 78 | 79 |
| Accumulated other comprehensive income | 2 | 3 |
| Additional paid-in capital | 574,943 | 581,800 |
| Accumulated deficit | (137,974) | (176,575) |
| TOTAL STOCKHOLDERS’ EQUITY | $437,049 | $405,307 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's common stock, par value (in dollars per share)?
- CorMedix (CRMD) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has CorMedix's common stock, par value (in dollars per share) changed year-over-year?
- CorMedix's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for CorMedix's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), CorMedix's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about CorMedix's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude